Search Results - "Crowder, Roslyn N"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    The Deubiquitinase Inhibitor PR-619 Sensitizes Normal Human Fibroblasts to Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)-mediated Cell Death by Crowder, Roslyn N., Dicker, David T., El-Deiry, Wafik S.

    Published in The Journal of biological chemistry (11-03-2016)
    “…TNF-related apoptosis-inducing ligand (TRAIL) is a potential cancer therapy that selectively targets cancer cell death while non-malignant cells remain viable…”
    Get full text
    Journal Article
  2. 2
  3. 3

    First-In-Class Small Molecule ONC201 Induces DR5 and Cell Death in Tumor but Not Normal Cells to Provide a Wide Therapeutic Index as an Anti-Cancer Agent by Allen, Joshua E, Crowder, Roslyn N, Crowder, Roslyn, El-Deiry, Wafik S

    Published in PloS one (18-11-2015)
    “…We previously identified ONC201 (TIC10) as a first-in-class orally active small molecule with robust antitumor activity that is currently in clinical trials in…”
    Get full text
    Journal Article
  4. 4

    B lymphocytes are resistant to death receptor 5-induced apoptosis by Crowder, Roslyn N, Zhao, Hong, Chatham, W. Winn, Zhou, Tong, Carter, Robert H

    Published in Clinical immunology (Orlando, Fla.) (01-04-2011)
    “…Abstract Death Receptor 5 (DR5) induces apoptosis in various types of cells and is a potential therapeutic target. We have investigated whether targeting DR5…”
    Get full text
    Journal Article
  5. 5

    Abstract 2938: Altered caspase-8 protein expression and activity in TRAIL-resistant normal human fibroblasts by Crowder, Roslyn N., Dicker, David T., El-Deiry, Wafik S.

    Published in Cancer research (Chicago, Ill.) (15-04-2013)
    “…Abstract TNF-related apoptosis-inducing ligand (TRAIL)-mediated cell death is currently being utilized in newly developed cancer therapies. The molecular basis…”
    Get full text
    Journal Article
  6. 6

    Abstract 252: Altered caspase-8 localization and decreased caspase-8 sumoylation in TRAIL-resistant normal human fibroblasts by Crowder, Roslyn N., Dicker, David T., El-Deiry, Wafik S.

    Published in Cancer research (Chicago, Ill.) (15-04-2012)
    “…Abstract TNF-related apoptosis-inducing ligand (TRAIL)-mediated cell death is currently being utilized in newly developed cancer therapies. The molecular basis…”
    Get full text
    Journal Article
  7. 7

    Abstract 4095: Decreased caspase 8 protein expression and incomplete caspase 3 activation in TRAIL-resistant normal human fibroblasts and epithelial cells by Crowder, Roslyn N., Dicker, David T., El-Deiry, Wafik S.

    Published in Cancer research (Chicago, Ill.) (15-04-2011)
    “…Abstract TNF-related apoptosis-inducing ligand (TRAIL)-mediated cell death is currently being utilized in newly developed cancer therapies. The molecular basis…”
    Get full text
    Journal Article
  8. 8

    Abstract 1042: Diminished caspase 8 and c-Myc protein expression in human fibroblasts provides insight into normal cell resistance to TRAIL-mediated apoptosis by Crowder, Roslyn N., Dicker, David T., El-Deiry, Wafik S.

    Published in Cancer research (Chicago, Ill.) (15-04-2010)
    “…Abstract TNF-related apoptosis-inducing ligand (TRAIL)-mediated cell death is currently being exploited in clinical trials for cancer therapy. However, the…”
    Get full text
    Journal Article